Strengthening regulatory systems for medicines in a changed world: where do we go from here?

BMJ Glob Health. 2021 Jan;6(1):e004680. doi: 10.1136/bmjgh-2020-004680.

Authors

Julie O'Brien¹, Rebecca Lumsden², Judith Macdonald²

Affiliations

¹ Global Regulatory Policy and Intelligence, Global Regulatory Affairs, Pfizer Healthcare Ireland, Dublin, Ireland julie.obrien@pfizer.com.
² Global Regulatory Policy and Intelligence, Global Regulatory Affairs, Pfizer Ltd, Tadworth, Surrey, UK.

No abstract available

Keywords: COVID-19; health policy; health systems; public health.

MeSH terms

Antiviral Agents
COVID-19
Global Health / legislation & jurisprudence*
Humans
Legislation, Drug*
Pandemics
Public Health / legislation & jurisprudence*
SARS-CoV-2

Substances

Antiviral Agents